Mechanism of the Hypoglycemic Effect of Stevioside, a Glycoside of Stevia rebaudiana
The DOI matches its Crossref record.
Abstract
We have studied the effects of stevioside on the glucose and insulin metabolism in 2 models of diabetes in rats, STZ-induced diabetic rats and NIDDM diabetic rats induced by feeding with fructose. Stevioside (0.5 mg/kg), lowered the blood glucose levels in STZ-induced diabetic rats, peaking at 90 min. Stevioside administered twice daily also demonstrated dose-dependent effects in lowering the glucose levels in both diabetic rat models. Stevioside reduced the rise in glucose during glucose tolerance testing in normal rats. Stevioside dose-dependently decreased protein levels of phosphoenol pyruvate carboxykinase (PEPCK) and PEPCK mRNA after 15 days of treatment. Stevioside also reduced insulin resistance in the diabetic animals as shown by the glucose lowering effects of tolbutamide. In conclusion, stevioside was able to regulate blood glucose levels by enhancing not only insulin secretion, but also insulin utilization in insulin-deficient rats; the latter was due to decreased PEPCK gene expression in rat liver by stevioside's action of slowing down gluconeogenesis. Further studies of this agent for the treatment of diabetes appear warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Stevioside and related compounds: Therapeutic benefits beyond sweetness
Chatsudthipong, V., & Muanprasat, C. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.09.007 · Cited by 467
Terpenes: substances useful in human healthcare
Paduch, R., Kandefer-Szerszeń, M., Trytek, M., & Fiedurek, J. (2007) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-007-0039-1 · Cited by 448
Stevia Leaf to Stevia Sweetener: Exploring Its Science, Benefits, and Future Potential
Samuel, P., Ayoob, K. T., Magnuson, B. A., Wölwer-Rieck, U., Jeppesen, P. B., Rogers, P. J., Rowland, I., & Mathews, R. (2018) · The Journal of Nutrition · doi:10.1093/jn/nxy102 · Cited by 189
Nutritional and therapeutic values of Stevia rebaudiana: A review
Gupta, E., Purwar, S., Sundaram, S., & K., G. (2013) · Journal of Medicinal Plants Research · doi:10.5897/jmpr2013.5276 · Cited by 165
“…glucose levels by enhancing not only insulin secretion, but also insulin utilization in insulin-deficient rats; which was due to decreased phosphoenolpyruvate carboxykinase (PEPCK) gene expression in rat liver by stevioside's action of slowing down gluconeogenesis suggested by Chen et al. (2005).”
BackgroundAntidiabetic effect of d-limonene, a monoterpene in streptozotocin-induced diabetic rats
Murali, R., & Saravanan, R. (2012) · Biomedicine & Preventive Nutrition · doi:10.1016/j.bionut.2012.08.008 · Cited by 163
Maki, K. C., Curry, L. L., Reeves, M. S., Toth, P. D., McKenney, J. M., Farmer, M. V., Schwartz, S. L., Lubin, B. C., Boileau, A. C., Dicklin, M. R., et al. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.05.007 · Cited by 160
“…microunits; mg, milligram; r; ng, nanogram; non-HDL-C, al cholesterol; U/L, units per : +1 952 742 7573. ileau). type 2 diabetes and hypertension (Chan et al., 1998; Chan et al., 2000; Jeppesen et al., 2000; Hsieh et al., 2003; Jeppesen et al., 2003; Gregersen et al., 2004; Chen et al., 2005).”
Schäfer, A., & Högger, P. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.10.011 · Cited by 136
Metadata
- Authors
- Chen, T.-H., Chen, S.-C., Chan, P., Chu, Y.-L., Yang, H.-Y., & Cheng, J.-T.
- Venue
- Planta Medica
- Publisher
- Georg Thieme Verlag KG
- Published
- 2005-02
- Volume
- 71
- Issue
- 2
- Pages
- 108-113
- ISSN
- 0032-0943 (ISSN-L)
- 1439-0221
- OpenAlex
- W2059169334
- Cited by
- 160
- References
- 0
- FWCI
- 2.37
- Type
- journal article
- Language
- de
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.